These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12553067)

  • 1. The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors.
    Yamamoto M; Ueno Y; Hayashi S; Fukushima T
    Anticancer Res; 2002; 22(6C):4265-8. PubMed ID: 12553067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of proteolytic enzymes in skin neoplasm progression and development of metastasis].
    Kozłowski L; Wojtukiewicz MZ
    Postepy Hig Med Dosw; 1999; 53(6):841-54. PubMed ID: 10737043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal caspase activity promotes migration and invasiveness in glioblastoma cells.
    Gdynia G; Grund K; Eckert A; Böck BC; Funke B; Macher-Goeppinger S; Sieber S; Herold-Mende C; Wiestler B; Wiestler OD; Roth W
    Mol Cancer Res; 2007 Dec; 5(12):1232-40. PubMed ID: 18171980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.
    Rao JS; Steck PA; Mohanam S; Stetler-Stevenson WG; Liotta LA; Sawaya R
    Cancer Res; 1993 May; 53(10 Suppl):2208-11. PubMed ID: 8485704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-type plasminogen activator system and breast cancer (Review).
    Han B; Nakamura M; Mori I; Nakamura Y; Kakudo K
    Oncol Rep; 2005 Jul; 14(1):105-12. PubMed ID: 15944776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of glioma invasiveness: the role of proteases.
    Rao JS
    Nat Rev Cancer; 2003 Jul; 3(7):489-501. PubMed ID: 12835669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF; Nadesapillai AP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of proteases in the growth, invasion and spread of cancer cells].
    Buø L; Aasen AO; Karlsrud TS; Johansen HT; Sivertsen SM
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3753-6. PubMed ID: 2274946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
    Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
    Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional measurement of local proteolytic activity in living cells of invasive and non-invasive tumors.
    Ludwig T; Püttmann S; Bertram H; Tatenhorst L; Paulus W; Oberleithner H; Senner V
    J Cell Physiol; 2005 Mar; 202(3):690-7. PubMed ID: 15389570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor.
    Mohanam S; Sawaya RE; Yamamoto M; Bruner JM; Nicholson GL; Rao JS
    J Neurooncol; 1994; 22(2):153-60. PubMed ID: 7745467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation.
    Belkacemi L; Lam E; Caldwell JD; Siemens DR; Graham CH
    Exp Cell Res; 2006 Jun; 312(10):1685-92. PubMed ID: 16564525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system.
    Lamy S; Lafleur R; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
    J Cell Biochem; 2007 Jan; 100(1):100-11. PubMed ID: 16823770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanidinobenzoatase and UPA in high-grade human astrocytomas and after xenografting cell suspensions into the rat cerebral cortex: proteases for metastasis and disease progression.
    Bernstein LJ; Tonn JC; Goldbrunner RH; Vince GH; Wagner S; Goldberg WJ
    Anticancer Res; 1998; 18(4A):2583-90. PubMed ID: 9703913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.